← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 27, 2020Last known activity
Aug 26, 2025
Timeline
2010s
- Jun 1, 2015
Relay Therapeutics, Inc.— Founded
2020s
- Apr 19, 2021
ZebiAI Therapeutics— Acquired
Drugs by trial phase (9 distinct, 6 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (6)
- NCT06982521Lead sponsorPhase 3Aug 26, 2025
- NCT06789913Lead sponsorPhase 2Mar 31, 2025
- NCT05759949Lead sponsorPhase 1Mar 29, 2023
- NCT05216432Lead sponsorPhase 1Dec 8, 2021
- NCT04526106Lead sponsorPhase 1Sep 2, 2020
- NCT04252339Lead sponsorPhase 1Jan 27, 2020
Details
- Founded
- Cambridge, MA, US Jun 1, 2015
- Last known activity
- Aug 26, 2025